Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2022 16:05 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

PHILADELPHIA, PA, May 09, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
April 22, 2022 08:00 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals Announces Review of Strategic Alternatives

Philadelphia, PA, April 22, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the...
March 23, 2022 08:00 ET | Source: Vallon Pharmaceuticals Inc.

Vallon Pharmaceuticals to Participate at the 5th Annual Neuroscience Innovation Forum

David Baker, President and CEO of Vallon to participate in the virtual Advances in Neuropsychiatry Panel, today, March 23rd at 9:00 AM ET Philadelphia, PA, March 23, 2022 (GLOBE NEWSWIRE) --...